Managing Anger and Irritability

Pharmacological Interventions

Mood stabilizers, atypical antipsychotics, and certain antidepressants are effective pharmacological interventions for managing anger and irritability, with medication selection based on the underlying diagnosis and symptom severity, as recommended by the American Academy of Child and Adolescent Psychiatry 1
For acute agitation/aggression, benzodiazepines (e.g., lorazepam 2-4 mg) and atypical antipsychotics (e.g., ziprasidone 20 mg IM, risperidone 0.5-1 mg) are effective for rapid control 2

For patients with ADHD, stimulants (e.g., methylphenidate, amphetamine derivatives) and atomoxetine can improve oppositional behavior when ADHD is the primary diagnosis 1
Mood stabilizers (e.g., divalproex sodium, lithium carbonate) are effective for chronic maladaptive aggression 1
Risperidone is recommended for irritability and aggression in children with pervasive developmental disorders and conduct disorder, with strong evidence supporting its use, as suggested by the American Academy of Child and Adolescent Psychiatry 3, 4, 5
Alternative medication options include aripiprazole, divalproex sodium, and alpha-2 agonists like Clonidine or Guanfacine, with dosing ranges and recommendations varying depending on the medication and patient population 6, 4, 7

The American Academy of Child and Adolescent Psychiatry recommends identifying the underlying diagnosis and targeting medication to the specific syndrome when comorbid conditions are present, starting with the lowest effective dose, and trying another medication in the same class or switching to a different class if the first medication is ineffective 1
Avoiding polypharmacy initially and trying sequential monotherapy before combining medications is also recommended by the American Academy of Child and Adolescent Psychiatry 1
Combining medication with behavioral approaches is more effective than medication alone for managing aggression, with regular reassessment of the need for continued medication essential, and attempts at dose reduction when clinically appropriate 8

Benzodiazepines have a risk of dependence and interactions with other drugs/alcohol, and the American Academy of Child and Adolescent Psychiatry recommends avoiding SSRIs as first-line agents unless major depressive disorder or anxiety is diagnosed along with irritability/anger, and monitoring medication adherence and possible diversion, especially with controlled substances 9, 1
Risperidone has specific and limited indications based on available evidence, including the treatment of irritability associated with autistic disorder in children and adolescents, but its use for self-harming behaviors is not supported by direct evidence 10
Common side effects of risperidone include increased appetite, weight gain, and metabolic changes, requiring regular monitoring of weight, BMI, lipids, and glucose 4
Other potential side effects include extrapyramidal symptoms, prolactin elevation, and QTc prolongation, with regular assessment and monitoring essential for early detection and management 4, 7

Functional Communication Training, Cognitive Behavioral Therapy (CBT), and parent training are effective behavioral interventions for managing agitation and selective mutism, with systematic review evidence indicating significant and large effects on improving speaking behavior 4, 6
De-escalation techniques, environmental modifications, and creating a calm, soothing environment can help manage neuroirritability and agitation in pediatric patients, as suggested by the American Academy of Pediatrics 6, 11, 12
Distraction techniques, relaxation, and mindfulness can be effective for children and adolescents who can participate, as suggested by the Ca-A Cancer Journal for Clinicians 13

Validated age-appropriate pain scales, such as the Numerical Rating Scale (NRS) and Revised Face Legs Activity Cry and Consolability (r-FLACC) scale, should be used to assess pain and irritability in pediatric patients, as recommended by the European Journal of Nuclear Medicine and Molecular Imaging 12
Prioritizing pain management is essential, as untreated pain elevates the risk for long-term neuropathic pain, and implementing preemptive analgesia for procedural pain can help minimize risks, as suggested by JAMA Pediatrics 14, 12
Establishing consistent bedtime routines, creating an environment conducive to sleep, and limiting daytime naps can help regulate sleep patterns and reduce irritability, and avoiding late-night electronic device use in adolescents can also help promote healthy sleep habits 13